Simeng Ding | Computational Biology | Best Researcher Award

Best Researcher Award

Simeng Ding

Jilin University, China

Simeng Ding
Affiliation Jilin University
Country China
Documents 2
Subject Area Computational Biology
Event Technology Scientists Awards
ORCID 0009-0006-5489-6975

Simeng Ding is a researcher affiliated with Jilin University whose documented work intersects Computational Biology, molecular enzymology, and sustainable biocatalysis. Her research includes enzyme engineering, computational screening, lactose hydrolysis, and glycoside synthesis. Two identified publications describe GH42 β-galactosidase engineering for whey lactose conversion and glycosidase-catalyzed galactosyl-sn-2-glycerol production. These studies combine computational analysis with biochemical experimentation, including sequence-informed design, molecular-level interpretation, kinetic evaluation, and reaction optimization. The work demonstrates an interdisciplinary approach to developing efficient enzyme-based processes and valorizing biochemical resources. Her publication record provides a basis for consideration under the Best Researcher Award category within a technology-focused research recognition.

Abstract

Simeng Ding is a researcher affiliated with Jilin University whose documented work intersects Computational Biology, molecular enzymology, and sustainable biocatalysis. Her research includes enzyme engineering, computational screening, lactose hydrolysis, and glycoside synthesis. Two identified publications describe GH42 β-galactosidase engineering for whey lactose conversion and glycosidase-catalyzed galactosyl-sn-2-glycerol production. These studies combine computational analysis with biochemical experimentation, including sequence-informed design, molecular-level interpretation, kinetic evaluation, and reaction optimization. The work demonstrates an interdisciplinary approach to developing efficient enzyme-based processes and valorizing biochemical resources. Her publication record provides a basis for consideration under the Best Researcher Award category within a technology-focused research recognition.

Keywords

Computational Biology; enzyme engineering; glycosidases; β-galactosidase; whey lactose; transglycosylation; galactosyl-sn-2-glycerol; biocatalysis; molecular enzymology; sustainable biotechnology.

Introduction

Simeng Ding’s research profile at Jilin University is associated with computational biology and enzyme-related research. Her documented publications address glycosidase engineering, lactose hydrolysis, transglycosylation, and computationally informed biocatalysis. These studies connect molecular-level analysis with practical bioprocessing objectives, illustrating an interdisciplinary approach spanning computational and biochemical methods in applied biotechnology research. [1] [2]

Research Profile

Simeng Ding is affiliated with Jilin University, China, and works in a research environment focused on molecular enzymology and engineering. Her publication record includes studies involving glycosidases, enzyme engineering, substrate conversion, and computational analysis. The available record identifies two documents, one citation, and a Computational Biology subject classification. Enzyme technology. [1] [2]

Research Contributions

Ding’s contributions include participation in the design and evaluation of enzyme-based strategies for lactose conversion and galactosylglycerol synthesis. Her research incorporates sequence-informed engineering, computational screening, kinetic analysis, solvent effects, and molecular-level interpretation. Together, these approaches support the development of more effective biocatalytic systems for sustainable biochemical production for industrial applications. [1] [2]

  • Enzyme engineering and computational screening for improved catalytic performance. [1]
  • Biocatalytic conversion of lactose and production of value-added galactosides. [1] [2]
  • Application of kinetic, thermodynamic, and molecular-level approaches to enzyme research. [2]

Publications

The available publication record comprises two research articles. One investigates consensus design and computational screening of GH42 β-galactosidase for improved whey lactose hydrolysis, while the other examines regio-stereoselective galactosyl-sn-2-glycerol synthesis through glycosidase-catalyzed transglycosylation. Both studies demonstrate the application of enzyme engineering and computationally supported biochemical research in contemporary enzyme research. [1] [2]

Research Impact

The reported research has relevance to sustainable biocatalysis, particularly through the conversion of lactose-containing resources and the synthesis of value-added galactosides. The studies demonstrate how enzyme engineering, computational screening, thermodynamic analysis, and reaction optimization can contribute to improved biochemical processes while supporting resource-efficient approaches to biotechnology in sustainable biotechnology research. [1] [2]

Award Suitability

Simeng Ding’s documented research aligns with the Best Researcher Award through its focus on enzyme-related computational biology, biocatalysis, and sustainable biochemical applications. Her involvement in peer-reviewed studies demonstrates research participation across enzyme engineering and reaction optimization. The available evidence supports recognition of emerging scholarly contributions within an interdisciplinary biotechnology context. [1] [2]

Conclusion

Simeng Ding’s research record reflects an interdisciplinary focus connecting computational biology with enzymology and sustainable bioprocessing. Her documented studies address enzyme engineering and glycoside synthesis using computational and experimental approaches. Based on the available publications and research profile, her work represents a relevant contribution to contemporary computationally supported biotechnology research. [1] [2]

References

    1. Ding, S., Li, J., Li, J., Nie, H., Li, Y., Guo, Z., & Gao, R. (2026). Consensus design and in silico screening of GH42 β-galactosidase for enhanced catalytic hydrolysis of whey lactose. Journal of Dairy Science. Advance online publication.
      https://doi.org/10.3168/jds.2026-29005
    2. Lyu, J., Ding, S., Wolff, C. D., Gao, R., & Guo, Z. (2026). Regio-Stereoselective synthesis of galactosyl-sn-2-glycerol by Thermotoga naphthophila glycosidase-catalyzed transglycosylation in a cosolvent-mediated system: Kinetic and thermodynamic insights. ACS Sustainable Chemistry & Engineering, 14(17), 8221–8232.
      https://doi.org/10.1021/acssuschemeng.6c00122
    3. Ding, S. (n.d.). ORCID profile. ORCID.
      https://orcid.org/0009-0006-5489-6975

Xuejun Xiao | Bioinformatics | Best Researcher Award

Best Researcher Award

                    Xuejun Xiao
Affiliation Xinjiang Medical University
Country China
Scopus ID 56640335200
Documents 8
Citations 132
h-index 4
Subject Area Bioinformatics
Event Technology Scientists Awards

Xuejun Xiao, Xinjiang Medical University

Xuejun Xiao is affiliated with Xinjiang Medical University, China, and has contributed to bioinformatics and biomedical research through scholarly publications indexed in Scopus. The researcher has authored eight indexed publications, received more than one hundred citations, and demonstrated continued academic engagement in cancer biology, immunology, and nanomedicine research. [1]

Abstract

Xuejun Xiao has contributed to interdisciplinary bioinformatics research with emphasis on cancer biology, immune regulation, molecular therapeutics, and nanoparticle-assisted drug delivery. Published studies investigate immune checkpoint modulation, mechanisms of chemotherapy resistance, and advanced biomedical technologies supporting precision medicine. The available scholarly record demonstrates sustained scientific productivity and measurable citation impact within indexed literature. These achievements indicate meaningful participation in translational biomedical research while supporting future innovation in computational biology, oncology, and therapeutic development through collaborative scientific investigation and evidence-based methodologies. [1] [2] [3]

Keywords

Bioinformatics, Cancer Research, Nanoparticles, Drug Delivery, Gastric Cancer, LUAD, Immunotherapy, Siglec-15, Precision Medicine, Computational Biology.

Introduction

Bioinformatics integrates computational methods with biomedical sciences to improve disease understanding and therapeutic discovery. Xuejun Xiao’s scholarly activities align with this interdisciplinary approach by examining molecular mechanisms associated with cancer progression, immune regulation, and targeted treatment strategies through evidence-based experimental investigations. [1]

Research Profile

The research profile demonstrates experience in oncology, molecular biology, and translational medicine. Indexed publications, citation performance, and collaborative scientific outputs illustrate continued participation in biomedical research focused on identifying clinically relevant biomarkers and innovative therapeutic approaches supporting improved patient outcomes. [2]

Research Contributions

Research contributions include investigations into nanoparticle-mediated antibody delivery, immune checkpoint inhibition, macrophage polarization, and mechanisms responsible for chemotherapy resistance. These studies provide valuable scientific knowledge supporting precision oncology and future therapeutic development through multidisciplinary biomedical research collaborations. [1] [3]

Publications

The Scopus record reports eight indexed publications covering bioinformatics, immunology, cancer biology, and targeted therapeutics. These publications have received academic recognition through citations, reflecting their relevance within contemporary biomedical research and contribution to ongoing scientific discussions in related disciplines. [1]

Research Impact

Citation metrics indicate measurable academic influence, with published research supporting continued investigations into molecular oncology and immunotherapy. The combination of citation performance, interdisciplinary collaborations, and translational relevance highlights the significance of the research within biomedical and bioinformatics communities. [2]

Award Suitability

Based on available scholarly indicators, publication quality, citation record, and sustained contributions to bioinformatics and biomedical sciences, Xuejun Xiao demonstrates qualifications consistent with recognition under the Best Researcher Award for advancing scientific knowledge through impactful and collaborative academic research. [1]

Conclusion

Xuejun Xiao’s academic portfolio reflects meaningful contributions to bioinformatics and cancer research through peer-reviewed publications addressing clinically important biomedical challenges. Continued research activity and scholarly collaboration are expected to further support innovation, translational medicine, and evidence-based healthcare advancement. [1]

External Links

References

  1. Xiao, X., et al. (2026). Application of nanoparticles in antibody drug delivery. Frontiers in Bioengineering and Biotechnology.
    https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1759915/full
  2. Xiao, X., et al. (2022). A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating macrophage polarization in the tumor microenvironment. Cancer Letters.
    https://www.sciencedirect.com/science/article/abs/pii/S1043661822002146
  3. Xiao, X., et al. (2020). PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis. Cell Biology International.
    https://pubmed.ncbi.nlm.nih.gov/32284742/
  4. Elsevier. (n.d.). Scopus author details: Xuejun Xiao, Author ID 56640335200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56640335200

Vasuk Gautam | Bioinformatics | Best Researcher Award

Dr. Vasuk Gautam | Bioinformatics | Best Researcher Award

Sr.Scientist | Norton Research Institute | United States

Dr. Vasuk Gautam is an emerging researcher whose work spans metabolomics, biomarker discovery, and computational methods for enhancing analytical confidence in high-throughput biological studies. With a record of 24 peer-reviewed publications, 13 h-index and over 3,102 citations, Gautam has established a strong early-career footprint marked by methodological innovation and extensive interdisciplinary collaboration. His contributions focus particularly on developing frameworks for improving metabolite identification accuracy—an essential challenge in metabolomics that directly influences the reliability of biomedical and environmental research. Notably, his recent work introducing the concept of “Identification Probability” provides a transferable, automated metric for evaluating identification confidence, positioning it as a potentially transformative tool for large-scale metabolomic pipelines. In parallel, Gautam has contributed significantly to the development of MarkerDB 2.0, a comprehensive biomarker database that integrates molecular, clinical, and contextual information to support precision medicine, translational research, and global health initiatives. His scholarship reflects a blend of computational rigor, domain expertise, and a commitment to open-access scientific resources. Gautam’s collaborations include partnerships with over 180 co-authors, underscoring his active engagement with diverse research groups and his ability to contribute meaningfully to multi-institutional projects. This collaborative network spans biochemistry, bioinformatics, systems biology, and clinical sciences, highlighting the broad applicability and relevance of his expertise. Through both his methodological contributions and his involvement in global data-resource efforts, Gautam’s work supports reproducibility, accessibility, and evidence-based discovery in molecular life sciences. His growing citation impact and participation in influential open-access initiatives demonstrate both scientific merit and societal relevance, particularly in areas related to disease diagnostics, personalized healthcare, and data-driven research infrastructures.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Wishart, D. S., Guo, A. C., Oler, E., Wang, F., Anjum, A., Peters, H., Dizon, R., … (2022). HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Research, 50(D1), D622–D631.

Cited by: 2116

2. Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., … (2024). DrugBank 6.0: The DrugBank knowledgebase for 2024. Nucleic Acids Research, 52(D1), D1265–D1275.

Cited by: 1112

3. Wishart, D. S., Han, S., Saha, S., Oler, E., Peters, H., Grant, J. R., Stothard, P., … (2023). PHASTEST: Faster than PHASTER, better than PHAST. Nucleic Acids Research, 51(W1), W443–W450.

Cited by: 394

4. Wishart, D. S., Tian, S., Allen, D., Oler, E., Peters, H., Lui, V. W., Gautam, V., … (2022). BioTransformer 3.0: A web server for accurately predicting metabolic transformation products. Nucleic Acids Research, 50(W1), W115–W123.

Cited by: 160

5. Wang, F., Allen, D., Tian, S., Oler, E., Gautam, V., Greiner, R., Metz, T. O., … (2022). CFM-ID 4.0: A web server for accurate MS-based metabolite identification. Nucleic Acids Research, 50(W1), W165–W174.

Cited by: 115

Dr. Vasuk Gautam’s work advances the reliability and scalability of metabolomic and biomarker research, enabling more accurate diagnostics and deeper biological insight. By developing robust identification metrics and contributing to global data resources, he helps accelerate scientific discovery, support precision medicine, and enhance evidence-based decision-making across research, healthcare, and industry.